GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceutical CPC1.JSC (HSTC:DP1) » Definitions » EV-to-EBITDA

Central Pharmaceutical CPC1.JSC (HSTC:DP1) EV-to-EBITDA : (As of May. 19, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Central Pharmaceutical CPC1.JSC EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Central Pharmaceutical CPC1.JSC's enterprise value is ₫0.00 Mil. Central Pharmaceutical CPC1.JSC does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Central Pharmaceutical CPC1.JSC's EV-to-EBITDA at this moment.

The historical rank and industry rank for Central Pharmaceutical CPC1.JSC's EV-to-EBITDA or its related term are showing as below:

HSTC:DP1's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 13.53
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-19), Central Pharmaceutical CPC1.JSC's stock price is ₫38600.00. Central Pharmaceutical CPC1.JSC does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Central Pharmaceutical CPC1.JSC's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Central Pharmaceutical CPC1.JSC EV-to-EBITDA Historical Data

The historical data trend for Central Pharmaceutical CPC1.JSC's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceutical CPC1.JSC EV-to-EBITDA Chart

Central Pharmaceutical CPC1.JSC Annual Data
Trend
EV-to-EBITDA

Central Pharmaceutical CPC1.JSC Semi-Annual Data
EV-to-EBITDA

Competitive Comparison of Central Pharmaceutical CPC1.JSC's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Central Pharmaceutical CPC1.JSC's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central Pharmaceutical CPC1.JSC's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Central Pharmaceutical CPC1.JSC's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Central Pharmaceutical CPC1.JSC's EV-to-EBITDA falls into.


;
;

Central Pharmaceutical CPC1.JSC EV-to-EBITDA Calculation

Central Pharmaceutical CPC1.JSC's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/
=


Central Pharmaceutical CPC1.JSC  (HSTC:DP1) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Central Pharmaceutical CPC1.JSC's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=38600.00/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Central Pharmaceutical CPC1.JSC EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Central Pharmaceutical CPC1.JSC's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Central Pharmaceutical CPC1.JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 87 Nguyen Van Troi Street, Thanh Xuan, Hanoi, VNM
Central Pharmaceutical CPC1.JSC is engaged in the trading of Raw materials and auxiliary materials for the production of drugs, medical products, and pharmaceutical packaging. Some of its products include Bupivacaine Spinal Heavy 0.5%; Vitamin B Complex; Syntarpen 1g and others.

Central Pharmaceutical CPC1.JSC Headlines

No Headlines